ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

A SERIES TO DETERMINE HYPERTENSION FREQUENCY AND COMPARE AVERAGE SERUM HS-C REACTIVE PROTEIN IN HYPERTENSIVE & NORMOTENSIVE PATIENTS

Dr. Syed Ubaid Hasnain, Dr. Waqas Akhtar, Dr. Kainat Arshad

Objectives: We aimed to determine hypertension frequency among those patients who were presented at the hospital; moreover, we also aimed to compare the average hs-C-reactive protein in both normotensive and hypertensive patients presented at the hospital. Methodology: We completed this comparative research at Medical Department of Sir Ganga Ram Hospital, Lahore on a total of 204 patients. All those patients who fulfilled the research inclusion criteria were made a part of this series after hospitalization. Patients also gave informed consent about the research protocols after receiving sufficient awareness about the objective of this research. They also gave information about the contact, age and name before the commencement of this research. Research himself monitored the blood pressure of every patient and categorized the patients as hypertensive (BP >140/90 mmHg) and hypertensive (BP < 140/90 mmHg). The blood pressure readings were taken at two consecutive intervals. The total research sample was also divided into two groups in order to compare the hs-C-reactive protein. Patients also gave a sample of blood for blood serum screening at the laboratory of the hospital. The same pathologist assessed the blood serum report of every patient and documented the hs-C-reactive protein level. Results: In the total research sample of 204 patients we divided the patients into two different age groups respectively of (40 – 50) years and (51 – 60) years. The age bracket of (40 – 50) years included 87 patients (42.65%) and age bracket of (51 – 60) years included 117 patients (57.35%). The mean age of the patients was (51.02 ± 5.88) years. In terms of gender distribution, we included 105 male (51.47%) and 99 female (48.53%) patients. There were 52 hypertensive patients (25.49%) and 152 normotensive patients (74.51%). The comparison between mean values of the hs-C-reactive protein of the hypertensive and normotensive patients was respectively calculated as (3.23 ± 0.83) mg/L and (1.58 ± 0.70) mg/L with a significant P-Value of (0.000). Conclusion: In the light of research outcomes we conclude about the average hs-C- reactive protein that it is high among hypertensive patients than the control group that is normotensive patients. However, an early C Reactive Protein screening is helpful to avoid delayed management and diagnosis of hypertension among affected patients. Keywords: Blood Pressure, Normotensive, Hypertensive, Hypertension, Hs-C-Reactive Protein, Blood Serum, Pathologist and Screening.

FULL TEXT